Cti Biopharma reported $2.44M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Baxter International BAX:US USD 1.23B 48M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Cti Biopharma CTIC:US USD 2.44M 654K
Eli Lilly And LLY:US USD 1.68B 23.9M
Mirati Therapeutics MRTX:US USD 19.45M 4.82M
Novartis NOVN:VX USD 4.69B 276M
Seattle Genetics SGEN:US USD 144.5M 15.63M
Teva Pharmaceutical Industries TEVA:US USD 1.64B 266M
YTE INCY:US USD 163.17M 31.6M